SHIM
DMTK

Stone House Investment Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Stone House Investment Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-118
Closed -$170 – 380
2023
Q3 		$170 Hold
118
– – ﹤0.01% 327
2023
Q2 		$307 Hold
118
– – ﹤0.01% 326
2023
Q1 		$434 Buy
+118
New +$497 ﹤0.01% 290

Other funds holding DMTK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return

Stone House Investment Management's DMTK Position: Q4 2023 in Review

Stone House Investment Management sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2023, closing a stake of 118 shares — an estimated $170 sold.

Stone House Investment Management first reported a position in DMTK in Q1 2023 and held it in 3 quarters. The position peaked at $434 in Q1 2023. 77 funds tracked by Wall St. Rank hold DMTK as of Q4 2023.

  • Stone House Investment Management reported no remaining DermTech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Stone House Investment Management sold 118 DermTech, Inc. Common Stock shares in Q4 2023, an estimated $170.
  • Stone House Investment Management first reported a position in DermTech, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Stone House Investment Management's DermTech, Inc. Common Stock position peaked at $434 in Q1 2023.
  • 77 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2023.

Based on Stone House Investment Management's 13F filing for Q4 2023, filed 31 Jan 2024.